Natco Pharma Ltd.
BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
917.90
3.05
(0.33%)
< Home
< Back
Natco Pharma Ltd. News
>>
Bombay HC upholds compulsory license granted to Natco Pharma on Nexavar
>>
Natco Pharma submits disclosure
>>
Natco Pharma spurts on filing ANDA for Bendamustine Hydrochloride powder
>>
Natco Pharma files ANDA for Bendamustine Hydrochloride powder
>>
Natco Pharma trades jubilantly on clearing legal hurdle to launch generic version of Copaxone
>>
Natco Pharma clears legal hurdle to launch generic version of Copaxone
>>
Natco Pharma urges Indian patent office to deny Gilead’s hepatitis C drug patent in India: Report
>>
Natco Pharma surges on receiving tentative approval from USFDA for Oseltamivir Phosphate Capsules
>>
Natco Pharma submits disclosure
>>
Natco Pharma board to consider Interim Dividend
<<
<
47
48
49
...52
>
>>